vs
Side-by-side financial comparison of B&G Foods, Inc. (BGS) and Enhabit, Inc. (EHAB). Click either name above to swap in a different company.
B&G Foods, Inc. is the larger business by last-quarter revenue ($439.3M vs $270.4M, roughly 1.6× Enhabit, Inc.). B&G Foods, Inc. runs the higher net margin — -4.4% vs -14.3%, a 10.0% gap on every dollar of revenue. On growth, Enhabit, Inc. posted the faster year-over-year revenue change (4.7% vs -4.7%). Enhabit, Inc. produced more free cash flow last quarter ($3.3M vs $-70.7M). Over the past eight quarters, Enhabit, Inc.'s revenue compounded faster (1.5% CAGR vs -12.8%).
B&G Foods, Inc. is an American branded foods holding company based in Parsippany, New Jersey. The company was formed in 1996 to acquire Bloch & Guggenheimer, a Manhattan-based producer of pickles, relish and condiments which had been founded in 1889.
Enhabit, Inc., is a Dallas, Texas-based provider of home health and hospice services. The company operates 255 home health and 110 hospice locations in 34 states with a concentration in Texas, Alabama, Florida, Georgia, Oklahoma and Mississippi. Enhabit is the fourth-largest provider of home health services in the United States and is a leading provider of hospice services. The company was formed in 2022 when Encompass Health spun off its home health and hospice business.
BGS vs EHAB — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $439.3M | $270.4M |
| Net Profit | $-19.1M | $-38.7M |
| Gross Margin | 22.5% | — |
| Operating Margin | 2.5% | -12.3% |
| Net Margin | -4.4% | -14.3% |
| Revenue YoY | -4.7% | 4.7% |
| Net Profit YoY | -356.5% | 15.9% |
| EPS (diluted) | $-0.24 | $-0.76 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $270.4M | ||
| Q3 25 | $439.3M | $263.6M | ||
| Q2 25 | $424.4M | $266.1M | ||
| Q1 25 | $425.4M | $259.9M | ||
| Q4 24 | $551.6M | $258.2M | ||
| Q3 24 | $461.1M | $253.6M | ||
| Q2 24 | $444.6M | $260.6M | ||
| Q1 24 | $475.2M | $262.4M |
| Q4 25 | — | $-38.7M | ||
| Q3 25 | $-19.1M | $11.1M | ||
| Q2 25 | $-9.8M | $5.2M | ||
| Q1 25 | $835.0K | $17.8M | ||
| Q4 24 | $-222.4M | $-46.0M | ||
| Q3 24 | $7.5M | $-110.2M | ||
| Q2 24 | $3.9M | $-200.0K | ||
| Q1 24 | $-40.2M | $200.0K |
| Q4 25 | — | — | ||
| Q3 25 | 22.5% | — | ||
| Q2 25 | 20.5% | — | ||
| Q1 25 | 21.2% | — | ||
| Q4 24 | 21.5% | — | ||
| Q3 24 | 22.2% | — | ||
| Q2 24 | 20.7% | — | ||
| Q1 24 | 22.9% | — |
| Q4 25 | — | -12.3% | ||
| Q3 25 | 2.5% | 6.4% | ||
| Q2 25 | 5.2% | 6.3% | ||
| Q1 25 | 8.4% | 6.1% | ||
| Q4 24 | -46.6% | -16.0% | ||
| Q3 24 | 11.1% | -38.6% | ||
| Q2 24 | 9.9% | 4.3% | ||
| Q1 24 | -3.3% | 4.9% |
| Q4 25 | — | -14.3% | ||
| Q3 25 | -4.4% | 4.2% | ||
| Q2 25 | -2.3% | 2.0% | ||
| Q1 25 | 0.2% | 6.8% | ||
| Q4 24 | -40.3% | -17.8% | ||
| Q3 24 | 1.6% | -43.5% | ||
| Q2 24 | 0.9% | -0.1% | ||
| Q1 24 | -8.5% | 0.1% |
| Q4 25 | — | $-0.76 | ||
| Q3 25 | $-0.24 | $0.22 | ||
| Q2 25 | $-0.12 | $0.10 | ||
| Q1 25 | $0.01 | $0.35 | ||
| Q4 24 | $-2.81 | $-0.92 | ||
| Q3 24 | $0.09 | $-2.20 | ||
| Q2 24 | $0.05 | $0.00 | ||
| Q1 24 | $-0.51 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $60.9M | $43.6M |
| Total DebtLower is stronger | $2.0B | $426.0M |
| Stockholders' EquityBook value | $470.7M | $534.0M |
| Total Assets | $2.9B | $1.2B |
| Debt / EquityLower = less leverage | 4.30× | 0.80× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $43.6M | ||
| Q3 25 | $60.9M | $56.9M | ||
| Q2 25 | $54.1M | $37.1M | ||
| Q1 25 | $61.2M | $39.5M | ||
| Q4 24 | $50.6M | $28.4M | ||
| Q3 24 | $54.7M | $45.7M | ||
| Q2 24 | $40.3M | $28.5M | ||
| Q1 24 | $42.5M | $36.5M |
| Q4 25 | — | $426.0M | ||
| Q3 25 | $2.0B | $441.5M | ||
| Q2 25 | $2.0B | $456.9M | ||
| Q1 25 | $2.0B | $467.3M | ||
| Q4 24 | $2.0B | $492.6M | ||
| Q3 24 | $2.1B | $502.9M | ||
| Q2 24 | $2.0B | $512.7M | ||
| Q1 24 | $2.0B | $526.7M |
| Q4 25 | — | $534.0M | ||
| Q3 25 | $470.7M | $566.8M | ||
| Q2 25 | $501.4M | $552.4M | ||
| Q1 25 | $513.1M | $543.2M | ||
| Q4 24 | $524.8M | $523.5M | ||
| Q3 24 | $755.3M | $566.1M | ||
| Q2 24 | $765.0M | $674.3M | ||
| Q1 24 | $781.2M | $672.3M |
| Q4 25 | — | $1.2B | ||
| Q3 25 | $2.9B | $1.2B | ||
| Q2 25 | $2.9B | $1.2B | ||
| Q1 25 | $3.0B | $1.2B | ||
| Q4 24 | $3.0B | $1.2B | ||
| Q3 24 | $3.4B | $1.3B | ||
| Q2 24 | $3.4B | $1.4B | ||
| Q1 24 | $3.4B | $1.4B |
| Q4 25 | — | 0.80× | ||
| Q3 25 | 4.30× | 0.78× | ||
| Q2 25 | 3.97× | 0.83× | ||
| Q1 25 | 3.91× | 0.86× | ||
| Q4 24 | 3.85× | 0.94× | ||
| Q3 24 | 2.75× | 0.89× | ||
| Q2 24 | 2.67× | 0.76× | ||
| Q1 24 | 2.61× | 0.78× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-64.6M | $4.4M |
| Free Cash FlowOCF − Capex | $-70.7M | $3.3M |
| FCF MarginFCF / Revenue | -16.1% | 1.2% |
| Capex IntensityCapex / Revenue | 1.4% | 0.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $54.8M | $65.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $4.4M | ||
| Q3 25 | $-64.6M | $37.8M | ||
| Q2 25 | $17.8M | $10.6M | ||
| Q1 25 | $52.7M | $17.9M | ||
| Q4 24 | $80.3M | $-4.1M | ||
| Q3 24 | $4.2M | $28.4M | ||
| Q2 24 | $11.3M | $9.6M | ||
| Q1 24 | $35.1M | $17.3M |
| Q4 25 | — | $3.3M | ||
| Q3 25 | $-70.7M | $36.2M | ||
| Q2 25 | $11.5M | $8.7M | ||
| Q1 25 | $42.4M | $17.6M | ||
| Q4 24 | $71.7M | $-4.7M | ||
| Q3 24 | $-679.0K | $27.7M | ||
| Q2 24 | $5.2M | $8.9M | ||
| Q1 24 | $27.5M | $15.5M |
| Q4 25 | — | 1.2% | ||
| Q3 25 | -16.1% | 13.7% | ||
| Q2 25 | 2.7% | 3.3% | ||
| Q1 25 | 10.0% | 6.8% | ||
| Q4 24 | 13.0% | -1.8% | ||
| Q3 24 | -0.1% | 10.9% | ||
| Q2 24 | 1.2% | 3.4% | ||
| Q1 24 | 5.8% | 5.9% |
| Q4 25 | — | 0.4% | ||
| Q3 25 | 1.4% | 0.6% | ||
| Q2 25 | 1.5% | 0.7% | ||
| Q1 25 | 2.4% | 0.1% | ||
| Q4 24 | 1.6% | 0.2% | ||
| Q3 24 | 1.0% | 0.3% | ||
| Q2 24 | 1.4% | 0.3% | ||
| Q1 24 | 1.6% | 0.7% |
| Q4 25 | — | — | ||
| Q3 25 | — | 3.41× | ||
| Q2 25 | — | 2.04× | ||
| Q1 25 | 63.17× | 1.01× | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.56× | — | ||
| Q2 24 | 2.87× | — | ||
| Q1 24 | — | 86.50× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BGS
| Specialty Segment | $150.5M | 34% |
| Meals Segment | $110.0M | 25% |
| Spices And Flavor Solutions Segment | $101.4M | 23% |
| Frozen And Vegetables Segment | $77.4M | 18% |
EHAB
| Third Party Payor Medicare | $111.6M | 41% |
| Third Party Payor Medicare Advantage | $67.5M | 25% |
| Hospice Segment | $63.6M | 24% |
| Third Party Payor Managed Care | $24.9M | 9% |
| Third Party Payor Medicaid | $1.7M | 1% |
